Viking Therapeutics, Inc. Stock Issued
Viking Therapeutics, Inc. (VKTX) reported Stock Issued of $1.80 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2019-03-13
- Viking Therapeutics, Inc. stock issued for the quarter ending 2017-12-31 was $0.00.
- Viking Therapeutics, Inc. stock issued for the quarter ending 2017-09-30 was $0.00.
- Viking Therapeutics, Inc. stock issued for the quarter ending 2017-06-30 was $0.00.
- Viking Therapeutics, Inc. stock issued for the quarter ending 2017-03-31 was $1.80M.
- Viking Therapeutics, Inc. stock issued for fiscal 2017 was $1.80M, a 308.83% increase from fiscal 2016.
- Viking Therapeutics, Inc. stock issued for fiscal 2016 was $440.28K.
| Period end | Stock Issued 3 month | Stock Issued 6 month | Stock Issued 9 month | Stock Issued 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $0.00 derived: sum of 2 quarters · filed 2019-03-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-13 | $1.80M 10-K · filed 2019-03-13 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $1.80M 10-Q · filed 2018-11-07 | $1.80M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.80M 10-Q · filed 2018-08-09 | $1.80M derived: sum of 3 quarters · filed 2018-08-09 | |
| 2017-03-31 | $1.80M 10-Q · filed 2018-05-09 | $1.80M derived: sum of 2 quarters · filed 2018-05-09 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $440.28K 10-K · filed 2017-03-21 | ||
| 2016-09-30 | $440.28K 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |